Proximal myopathy due to beta-galactosidase deficiency: a case report

The manifestations of beta-galactosidase deficiency range from Morquio syndrome type B (mucopolysacharidosis type IVB manifesting as spondyloepiphyso-metaphyseal osteodysplasia) to GM1 gangliosidosis (a more or less early neurodegenerative disease).

A Danish team describes for the first time the case of a young woman with limb-girdle myopathy without neurological damage or bone abnormalities, due to recessive mutations in the GLB1 gene.

  • As a child, she ran more slowly than her peers, but this did not prevent her from riding a bicycle or roller skating.
  • At the age of 19, she had difficulty climbing stairs.
  • At the age of 30 she started to show signs of respiratory impairment and frequent falls, as well as the onset of cataracts and tinnitus.
  • At 41 years of age, the amyotrophy is severe in the thighs and shoulders; she cannot get up from the floor without support and walks with a waddle in hyperlordosis.
  • Her vital capacity is 52% of the theoretical vital capacity.
  • The residual levels of β-galactosidase activity are 28% and 35%.

 

β-Galactosidase deficiency in the GLB1 spectrum of lysosomal storage disease can present with severe muscle weakness and atrophy. Pedersen JJ, Duno M, Wibrand F et al. JIMD Rep. 2022 Sep 6;63(6):540-545.